Day Trader తెలుగు
11:40 · May 25, 2023 · Thu
LINCOLN PHARMA: Q4 EBITDA RUPEES 166M VS 174M (YOY) || Q4 EBITDA MARGIN 14.76% VS 17.00% (YOY)
Please enable JavaScript to view the
comments powered by Disqus.
Home